This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fox, J. FDA scrutinizes human stem cell therapies. Nat Biotechnol 26, 598–599 (2008). https://doi.org/10.1038/nbt0608-598
Issue Date:
DOI: https://doi.org/10.1038/nbt0608-598
This article is cited by
-
Embryonic stem cells: are useful in clinic treatments?
Journal of Physiology and Biochemistry (2011)
-
Product Regulation and the Clinical Translation of Stem Cell Research
Stem Cell Reviews and Reports (2009)
-
The Role of Animal Models in Evaluating Reasonable Safety and Efficacy for Human Trials of Cell-Based Interventions for Neurologic Conditions
Journal of Cerebral Blood Flow & Metabolism (2009)